Publications
NK Cells
Publication Date: June 5, 2019
Introducing the gain-of-function CXCR4 variant R334X into expanded human NK cells by mRNA electroporation improved their homing to bone marrow in mice. Overnight IL-2 activation, cryopreservation and ex vivo expansion lowered CXCR4 on NK cells and reduced migration toward SDF-1α in vitro. NK cells expanded from three WHIM syndrome patients, who carry CXCR4 R334X, showed similar CXCR4 surface levels yet homed much more strongly to NSG mouse bone marrow. Electroporation with a MaxCyte GT instrument raised CXCR4 transiently, peaking 4–8 h and returning to baseline by 36–48 h, without changing viability, phenotype or cytotoxicity. R334X-engineered cells migrated better toward 25 and 50 ng/mL…
Publications
Other
G-Rex®10
Publication Date: March 29, 2019
Mycobacteria-specific T cells can be expanded from healthy donors in 10 to 12 days using peptide pools from five mycobacterial antigens, but they are largely absent in patients with primary immunodeficiency and invasive mycobacterial infection. Cultures from ten healthy donors, six of them BCG-vaccinated, showed a mean 4.4-fold expansion with 7–11 × 10^7 cells recovered. Products were mostly CD4+ effector cells recognizing a median of 3 of 5 antigens and producing IFN-γ, TNF and GM-CSF. By contrast, only two of seven PID patients showed antigen-specific responses, while both patients with anti-IFN-γ autoantibodies responded. Lysate- or sensitin-expanded cultures gave comparable specificit…
Publications
NK Cells
G-Rex®100
Publication Date: March 20, 2019
Engineered with a transient NKG2D–DAP12 mRNA CAR by electroporation, NK cells showed stronger killing of solid tumor cell lines in vitro and extended survival in HCT116 xenograft mice; in a pilot trial of three patients with chemotherapy-refractory metastatic colorectal cancer, local infusion was well tolerated and produced signs of antitumor activity. NK cells were expanded from blood on K562 feeder cells expressing mbIL-15, 4-1BBL and mbIL-21, in G-Rex® 100 vessels, with viability above 90% before infusion. In mice, median survival was prolonged by 92% versus PBS and 53% versus mock NK cells. Two patients with malignant ascites had fewer cancer cells in ascites and lower daily ascites v…
Publications
NK Cells
Publication Date: March 12, 2019
Extracellular vesicles released by expanded human natural killer cells kill cancer cells through several cytotoxic proteins and more than one death pathway, with no single protein dominating. Across more than 60 vesicle preparations, perforin averaged about 550 ng/mL, granzyme A 185, granulysin 56, granzyme B 23.4 and FasL 2.5 ng/mL. Perforin, granzymes A and B and granulysin correlated moderately with killing of neuroblastoma and leukaemia cells (R-squared 0.13 to 0.35), whereas FasL barely correlated. In treated target cells, the granzyme A substrates SET and HMG2 decreased, cytochrome C moved from mitochondria into the cytosol, and endoplasmic reticulum stress markers changed, indicati…
Publications
CD34 Cells, Other
G-Rex®24 Well Plate, G-Rex®6 Well Plate
Publication Date: March 8, 2019
Seeding mobilized peripheral blood CD34+ cells on a gas-permeable G-Rex® membrane for the first 5 days, together with fed-batch media dilutions, produced more megakaryocytes than standard plates with full media exchanges. At 40 × 10^3 cells per cm2 with dilutions on days 5 and 7 (G40D), peak output was 39 CD41+CD42b+ megakaryocytes per input CD34+ cell, against 18 for standard culture and 28 for diluted standard culture (11 donors). G40D also gave 1.5-fold more CD34+ cells by day 7 and about threefold more megakaryocytes per milliliter of media. Mean ploidy was lower, but high-ploidy megakaryocytes per input cell rose from 6 to 9. The cells formed proplatelets and platelet-like particles…
Publications
Other
Publication Date: February 27, 2019
Kirigami-patterned passive resonant sensors can wirelessly report large extensions, with gain tunable by coil geometry and coating. Extension pulls the coil out of plane, which lowers its capacitance and inductance and raises the resonant frequency. Copper-coated polyimide Archimedean spirals were laser cut and read with a vector network analyzer, showing a 90 MHz resonant frequency shift for a 10 cm stretch over a 0–22 cm range. Gain increased linearly with coil pitch (R² of 0.99) and stayed constant over 96 stretch cycles at about 14 MHz per cm for a 5 mm pitch. Coating with polydimethylsiloxane allowed operation in a water-filled pipe, where the 1 mm coating gave the largest gain, 0.17…
Publications
TIL Cells
Publication Date: February 14, 2019
Treating BRAF inhibitor–resistant melanoma with a BRAF inhibitor temporarily raised surface mannose-6-phosphate receptor (M6PR), which let tumor cells take up granzyme B and made them more vulnerable to killing by tumor-infiltrating lymphocytes (TIL). In human melanoma cell lines, including lines made resistant to the inhibitor, PLX4720 increased M6PR, and deleting M6PR removed the added killing and granzyme B uptake. In mice bearing resistant WM35-BR tumors, PLX4720 or TIL alone did not slow growth, but the combination did. In a pilot trial of vemurafenib followed by TIL therapy, 6 of 16 accrued patients (38%) had an objective response, and tumor M6PR scores rose on treatment (p=0.003).
Publications
TIL Cells
G-Rex®100
Publication Date: February 11, 2019
Low-dose subcutaneous interleukin-2 after tumor-infiltrating lymphocyte (TIL) transfer was feasible and clinically active in 12 patients with unresectable metastatic melanoma, all but one of whom had progressed on checkpoint inhibitors. Patients received non-myeloablative lymphodepleting chemotherapy, an infusion of autologous TIL, and IL-2 at 125,000 IU/kg/day, averaging 6.8 doses. By RECIST v1.1, two patients had a partial response, one had an unconfirmed partial response and six had stable disease, meeting the prespecified efficacy threshold, although no complete response occurred and no partial response was durable. The rapid expansion yielded an average 2619-fold expansion and 1.12 ×…
Publications
TCR T Cells, TIL Cells
G-Rex®100
Publication Date: February 1, 2019
T cells from a patient with metastatic colorectal cancer recognized the shared p53 R175H neoantigen presented by HLA-A*0201, and three T-cell receptors were identified from them. Whole-exome sequencing of two lung metastases found 171 nonsynonymous mutations, and screening of 24 tumor fragments identified p53 p.R175H reactivity in CD8 T cells, with minimal epitope HMTEVVRHC. Three TCRs from tetramer-sorted cells, expressed in donor lymphocytes, recognized peptide at concentrations as low as 25 ng/mL and tumor lines expressing HLA-A*0201 and the mutation, including ovarian, uterine, myeloma and esophageal adenocarcinoma lines. The patient received 91.8 × 10^9 TIL cells with pembrolizumab;…
Publications
Treg Cells
G-Rex®10, G-Rex®100
Publication Date: February 1, 2019
Treg expansion was moved from manual G-Rex® culture to the closed, automated CliniMACS Prodigy system, which produced Treg with expansion kinetics and phenotype similar to the manual process. Polyclonal Treg were isolated from healthy-donor leukapheresis by CD8 depletion and CD25 enrichment, then expanded for 13–14 days with rapamycin, IL-2 and anti-CD3/CD28 beads. Prodigy cultures reached 0.33 to 2.12 × 10^9 cells on day 13. Purity after expansion was 92.8% versus 95.6% for parallel G-Rex®10 cultures (p = 0.08), and suppressive capacity was comparable across three donors. An automated bead-removal and formulation process reached 62% recovery with fewer than 400 residual beads per 100 × 1…
Publications
CAR T Cells, NK Cells
Publication Date: January 16, 2019
Natural killer cells engineered with a chimeric NKG2D.ζ receptor kill myeloid-derived suppressor cells and restore GD2 CAR-T cell activity in a neuroblastoma xenograft model containing human MDSCs. NKG2D.ζ–NK cells killed autologous MDSCs (35% versus 8% for unmodified NK cells at a 5:1 ratio) and, unlike native NKG2D, kept their function in the presence of TGFβ and soluble ligands. In mice, 1×10^7 cells left 8.7% of input MDSCs in tumors. A dose of 5×10^6 given three days before GD2.CAR-T cells raised CAR-T infiltration into the tumor core from 39% to 70% and extended median survival from 39 to 120 days, with durable cure in 2 of 5 mice. Cells generated from patient PBMCs also killed MDSC…
Publications
VST Cells
G-Rex®10
Publication Date: December 31, 2018
An accelerated co-cultured dendritic cell (acDC) method, adapted from peripheral blood work, can expand adenovirus-reactive CD8+ T cells from small amounts of cord blood mononuclear cells in 10 days. Cytokine cocktails differentiated dendritic cells in situ from unfractionated cord blood cells with a phenotype similar to peripheral blood. Under GM-CSF/IL-4 stimulation, adding IL-2 and IL-15 raised the number of MelanA-reactive CD8+ T cells 17-fold, and culture in G-Rex® flasks produced an 11-fold increase over plate culture. From 10 × 10^6 frozen-thawed cells, two representative donors yielded 3.9 × 10^5 and 6.0 × 10^5 AdV5-reactive CD8+ T cells, which the authors consider sufficient for…
No manuscripts match your filters.